Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
01/10/2026 12:05
BRIEF-Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study Oct 1 (Reuters) - Flerie AB FLERIE.ST:
FLERIE'S PORTFOLIO COMPANY ATROGI REPORTS POSITIVE DATA FROM A CLINICAL PROOF-OF-MECHANISM STUDY OF ATR-258 IN OVERWEIGHT OR OBESE INDIVIDUALS
Source text: ID:nMFN15jWNN
Further company coverage: FLERIE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen